Static renal parenchyma imaging would be best performed with which of the following radiopharmaceuticals?

Static renal parenchyma imaging is best performed with 99mTc succimer because this radiopharmaceutical is specifically designed for evaluating renal cortical function and anatomy. 99mTc succimer is a radioisotope that binds to the renal cortex, allowing for the visualization of the renal parenchyma in static images, which makes it particularly useful for detecting conditions such as renal scarring or assessing renal function.

When conducting static imaging, it's essential to use a radiopharmaceutical that localizes in the renal tissue effectively and provides clear images of the renal cortex. 99mTc succimer's high renal localization and its ability to highlight renal structure are advantageous compared to other options.

In contrast, 99mTc pentetate (commonly used for glomerular filtration rate measurements) and 99mTc mertiatide (often utilized for renal dynamic studies) do not have the same affinity for the renal cortex's static imaging. These agents are more appropriate for evaluating renal function, rather than providing detailed structural information of the renal parenchyma. 99mTc gluceptate, while also used to study renal function, does not offer the same level of cortical specificity needed for static parenchyma imaging.

Therefore